Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol
International Journal of Neuropsychopharmacology, 09/09/2009
Potkin SG et al. – In this long–term, double–blind study, ziprasidone treatment was more likely to result in remission than haloperidol treatment, and was associated with greater improvement in quality–of–life.







